RACTX | RHCTX | RACTX / RHCTX | |
Total Expense Ratio | 1.39 | 0.44 | 316% |
Annual Report Gross Expense Ratio | 1.39 | 0.44 | 316% |
Fund Existence | 19 years | 10 years | - |
Gain YTD | 8.271 | 8.846 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.1B | 15.1B | 100% |
Annual Yield % from dividends | 1.83 | 2.70 | 68% |
Returns for 1 year | 8.83 | 9.77 | 90% |
Returns for 3 years | 20.13 | 22.76 | 88% |
Returns for 5 years | 16.63 | 21.05 | 79% |
Returns for 10 years | 33.45 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MRFOX | 33.34 | 0.13 | +0.39% |
Marshfield Concentrated Opportunity | |||
JFNNX | 67.14 | 0.25 | +0.37% |
Janus Henderson Global Life Sciences N | |||
BRWBX | 25.78 | 0.07 | +0.27% |
MFS Blended Research Growth Eq B | |||
FCNKX | 23.86 | 0.05 | +0.21% |
Fidelity Contrafund K | |||
RTIYX | 12.05 | -0.03 | -0.25% |
Russell Inv Multifactor Intl Eq Y |